---
document_datetime: 2025-08-19 14:27:26
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ultomiris-epar-all-authorised-presentations_en.pdf
document_name: ultomiris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.4796049
conversion_datetime: 2025-12-24 02:18:46.466235
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/19/1371/002 Ultomiris 300 mg Concentrate for solution for infusion Intravenous use vial (glass) 3 ml (100 mg/ml) 1 vial EU/1/19/1371/003 Ultomiris 1100 mg Concentrate for solution for infusion Intravenous use vial (glass) 11 ml (100 mg/ml) 1 vial